Laserfiche WebLink
<br />.' In keeping with RECEIVING AGENCY'S entrepreneurial efforts, it is RECEIVING AGENCY <br />program's intent to encourage the use of locally eamed Medicaid funds to pay for or offset <br />significantly the cost of the statewide syphilis, gonorrhea, and chlamydia testing programs. To <br />accomplish this, PERFORMING AGENCY laboratories should bill Medicaid for eligible patients, <br />and purchase testing reagents for syphilis, gonorrhea, and cWamydia, in part or whole, at a state <br />negotiated price, to cover the current and expanding workload. <br /> <br />Program income in excess of the reagent costs should be utilized by PERFORMING AGENCY to <br />further the program objectives of the state statute under which the Scope ofW ork for the Attachment <br />was made. <br /> <br />General Provisions, FINANCIAL REPORTS Article is not applicable to this Attachment. <br /> <br />REIMBURSEMENT: <br /> <br />Support for this Scope of Work is provided by RECEIVING AGENCY under fmancial assistance <br />Supplies category and under direct assistance laboratory Support category for supplies through <br />reagents drop-shipped. Funding provided under Supplies must be used for requisition of supplies <br />to support RECEIVING AGENCY'S testing requirements. It is the PERFORMING AGENCY'S <br />responsibility to maintain all appropriate records required for audits that may be performed by <br />RECEIVING AGENCY. Any change in the allotment amount must be approved by RECEIVING <br />AGENCY'S Chief, Bureau of Laboratories. <br /> <br />ATTACHMENT - Page 2 <br />